FDA clears ROSA ONE Brain application
Zimmer Biomet announced FDA clearance of ROSA ONE Brain for robotic navigation and positioning in neurosurgical procedures.
Evidence notes
- The application supported biopsy, SEEG, DBS and ventricular and transnasal endoscopy.
- Zimmer Biomet described ROSA ONE Brain as the next generation of its ROSA Brain platform.
- The clearance established the Brain application separately from the then-pending Spine application.
Company context
Zimmer Biomet develops orthopedic products and ROSA robotic systems for knee, hip, shoulder and neurosurgical workflows.